IROBOT CORP (IRBT) Fundamental Analysis & Valuation

NASDAQ:IRBT • US4627261005

0.4664 USD
-0.2 (-30.05%)
At close: Dec 19, 2025
0.4999 USD
+0.03 (+7.18%)
After Hours: 12/19/2025, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This IRBT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

Taking everything into account, IRBT scores 1 out of 10 in our fundamental rating. IRBT was compared to 60 industry peers in the Household Durables industry. Both the profitability and financial health of IRBT have multiple concerns. While showing a medium growth rate, IRBT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. IRBT Profitability Analysis

1.1 Basic Checks

  • IRBT had negative earnings in the past year.
  • IRBT had a negative operating cash flow in the past year.
  • In multiple years IRBT reported negative net income over the last 5 years.
  • In the past 5 years IRBT reported 4 times negative operating cash flow.
IRBT Yearly Net Income VS EBIT VS OCF VS FCFIRBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M -300M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -43.34%, IRBT is doing worse than 95.08% of the companies in the same industry.
Industry RankSector Rank
ROA -43.34%
ROE N/A
ROIC N/A
ROA(3y)-34.67%
ROA(5y)-17.81%
ROE(3y)-150.96%
ROE(5y)-86.07%
ROIC(3y)N/A
ROIC(5y)N/A
IRBT Yearly ROA, ROE, ROICIRBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

  • IRBT's Gross Margin of 23.24% is on the low side compared to the rest of the industry. IRBT is outperformed by 62.30% of its industry peers.
  • In the last couple of years the Gross Margin of IRBT has declined.
  • IRBT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.94%
GM growth 5Y-13.55%
IRBT Yearly Profit, Operating, Gross MarginsIRBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. IRBT Health Analysis

2.1 Basic Checks

  • IRBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • IRBT has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for IRBT has been increased compared to 5 years ago.
  • Compared to 1 year ago, IRBT has a worse debt to assets ratio.
IRBT Yearly Shares OutstandingIRBT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
IRBT Yearly Total Debt VS Total AssetsIRBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • Based on the Altman-Z score of -1.51, we must say that IRBT is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of IRBT (-1.51) is worse than 93.44% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.51
ROIC/WACCN/A
WACC9.27%
IRBT Yearly LT Debt VS Equity VS FCFIRBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 0.52 indicates that IRBT may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.52, IRBT is doing worse than 96.72% of the companies in the same industry.
  • A Quick Ratio of 0.22 indicates that IRBT may have some problems paying its short term obligations.
  • IRBT has a worse Quick ratio (0.22) than 96.72% of its industry peers.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.22
IRBT Yearly Current Assets VS Current LiabilitesIRBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. IRBT Growth Analysis

3.1 Past

  • IRBT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.58%, which is quite good.
  • IRBT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -33.08%.
  • The Revenue for IRBT have been decreasing by -10.90% on average. This is quite bad
EPS 1Y (TTM)14.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-866.67%
Revenue 1Y (TTM)-33.08%
Revenue growth 3Y-24.19%
Revenue growth 5Y-10.9%
Sales Q2Q%-24.63%

3.2 Future

  • Based on estimates for the next years, IRBT will show a very strong growth in Earnings Per Share. The EPS will grow by 33.99% on average per year.
  • IRBT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.89% yearly.
EPS Next Y35.33%
EPS Next 2Y33.99%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-28.71%
Revenue Next 2Y9.89%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IRBT Yearly Revenue VS EstimatesIRBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
IRBT Yearly EPS VS EstimatesIRBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 4 -4 -6 -8

More info and screens

Find the best growth stocksShow best growing peers

1

4. IRBT Valuation Analysis

4.1 Price/Earnings Ratio

  • IRBT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year IRBT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IRBT Price Earnings VS Forward Price EarningsIRBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IRBT Per share dataIRBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

  • A more expensive valuation may be justified as IRBT's earnings are expected to grow with 33.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.99%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. IRBT Dividend Analysis

5.1 Amount

  • IRBT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IRBT Fundamentals: All Metrics, Ratios and Statistics

IROBOT CORP

NASDAQ:IRBT (12/19/2025, 8:00:02 PM)

After market: 0.4999 +0.03 (+7.18%)

0.4664

-0.2 (-30.05%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)11-06
Earnings (Next)05-04
Inst Owners39.47%
Inst Owner Change-83.29%
Ins Owners3.27%
Ins Owner Change-2.1%
Market Cap14.85M
Revenue(TTM)547.00M
Net Income(TTM)-208.72M
Analysts43.33
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)70.84%
Min EPS beat(2)65.31%
Max EPS beat(2)76.37%
EPS beat(4)2
Avg EPS beat(4)18.52%
Min EPS beat(4)-50.53%
Max EPS beat(4)76.37%
EPS beat(8)5
Avg EPS beat(8)32.32%
EPS beat(12)6
Avg EPS beat(12)-56.92%
EPS beat(16)8
Avg EPS beat(16)-48.15%
Revenue beat(2)2
Avg Revenue beat(2)2.57%
Min Revenue beat(2)0.05%
Max Revenue beat(2)5.1%
Revenue beat(4)2
Avg Revenue beat(4)-5.48%
Min Revenue beat(4)-20.34%
Max Revenue beat(4)5.1%
Revenue beat(8)3
Avg Revenue beat(8)-4.9%
Revenue beat(12)4
Avg Revenue beat(12)-8.65%
Revenue beat(16)4
Avg Revenue beat(16)-10.36%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.51
EYN/A
EPS(NY)-1.13
Fwd EYN/A
FCF(TTM)-3.36
FCFYN/A
OCF(TTM)-3.36
OCFYN/A
SpS17.18
BVpS-0.84
TBVpS-6.67
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -43.34%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.24%
FCFM N/A
ROA(3y)-34.67%
ROA(5y)-17.81%
ROE(3y)-150.96%
ROE(5y)-86.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.94%
GM growth 5Y-13.55%
F-Score4
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.22
Altman-Z -1.51
F-Score4
WACC9.27%
ROIC/WACCN/A
Cap/Depr(3y)11.65%
Cap/Depr(5y)43.11%
Cap/Sales(3y)0.46%
Cap/Sales(5y)1.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-866.67%
EPS Next Y35.33%
EPS Next 2Y33.99%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-33.08%
Revenue growth 3Y-24.19%
Revenue growth 5Y-10.9%
Sales Q2Q%-24.63%
Revenue Next Year-28.71%
Revenue Next 2Y9.89%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-104.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year117.97%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-4377.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1288.32%
OCF growth 3YN/A
OCF growth 5YN/A

IROBOT CORP / IRBT FAQ

What is the fundamental rating for IRBT stock?

ChartMill assigns a fundamental rating of 1 / 10 to IRBT.


What is the valuation status of IROBOT CORP (IRBT) stock?

ChartMill assigns a valuation rating of 1 / 10 to IROBOT CORP (IRBT). This can be considered as Overvalued.


What is the profitability of IRBT stock?

IROBOT CORP (IRBT) has a profitability rating of 0 / 10.


How financially healthy is IROBOT CORP?

The financial health rating of IROBOT CORP (IRBT) is 0 / 10.